Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 28

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A

Olivieri, Cristina, Walker, Caitlin, Karamafrooz, Adak, Wang, Yingjie, Manu, V. S., Porcelli, Fernando, Blumenthal, Donald K., Thomas, David D., Bernlohr, David A., Simon, Sanford M., Taylor, Susan S., Veglia, Gianluigi · 2021 · Communications Biology

Abstract

An aberrant fusion of the DNAJB1 and PRKACA genes generates a chimeric protein kinase (PKA-C DNAJB1) in which the J-domain of the heat shock protein 40 is fused to the catalytic α subunit of cAMP-dependent protein kinase A (PKA-C). Deceivingly, this chimeric construct appears to be fully functional, as it phosphorylates canonical substrates, forms holoenzymes, responds to cAMP activation, and recognizes the endogenous inhibitor PKI. Nonetheless, PKA-C DNAJB1 has been recognized as the primary driver of fibrolamellar hepatocellular carcinoma and is implicated in other neoplasms for which the molecular mechanisms remain elusive. Here we determined the chimera’s allosteric response to nucleotide and pseudo-substrate binding. We found that the fusion of the dynamic J-domain to PKA-C disrupts the internal allosteric network, causing dramatic attenuation of the nucleotide/PKI binding cooperativity. Our findings suggest that the reduced allosteric cooperativity exhibited by PKA-C DNAJB1 alters specific recognitions and interactions between substrates and regulatory partners contributing to dysregulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42003-021-01819-6

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 62

  1. Liu, S., Chan, K. W., Wang, B. & Qiao, L. Fibrolamellar hepatocellular carcinoma. Am. J. Gastroenterol. 104, 2617–2624 (2009). quiz 2625. · DOI
  2. Weeda, V. B. et al. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma–results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience. Eur. J. cancer 49, 2698–2704 (2013). · doi:10.1016/j.ejca.2013.04.012
  3. Katzenstein, H. M. et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 97, 2006–2012 (2003). · doi:10.1002/cncr.11292
  4. Mavros, M. N., Mayo, S. C., Hyder, O. & Pawlik, T. M. A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma. J. Am. Coll. Surg. 215, 820–830 (2012). · DOI
  5. El-Serag, H. B. & Davila, J. A. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatol. (Baltim., Md.) 39, 798–803 (2004). · doi:10.1002/hep.20096
  6. Simon, E. P. et al. Transcriptomic characterization of fibrolamellar hepatocellular carcinoma. Proc. Natl Acad. Sci. USA 112, E5916–5925 (2015). · DOI
  7. Honeyman, J. N. et al. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science 343, 1010–1014 (2014). · DOI · Paper page
  8. Graham, R. P. et al. DNAJB1-PRKACA is specific for fibrolamellar carcinoma. Mod. Pathol. 28, 822–829 (2015). · DOI · Paper page
  9. Xu, L. et al. Genomic analysis of fibrolamellar hepatocellular carcinoma. Hum. Mol. Genet. 24, 50–63 (2014). · DOI
  10. Johnson, D. A., Akamine, P., Radzio-Andzelm, E., Madhusudan, M. & Taylor, S. S. Dynamics of cAMP-dependent protein kinase. Chem. Rev. 101, 2243–2270 (2001). · DOI · Paper page
  11. Jedrzejewski, P. T. et al. A conserved deamidation site at asn 2 in the catalytic subunit of mammalian cAMP-dependent protein kinase detected by capillary LC-MS and tandem mass spectrometry. Protein Sci. 7, 457–469 (1998). · doi:10.1002/pro.5560070227
  12. Cheung, J. et al. Structural insights into mis-regulation of protein kinase A in human tumors. Proc. Natl Acad. Sci. USA 112, 1374–1379 (2015). · DOI · Paper page
  13. Riggle, K. M. et al. Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma. Pediatr. Res. 80, 110–118 (2016). · DOI
  14. Cao, B. et al. Structures of the PKA RIα holoenzyme with the FLHCC Driver J-PKAcα or Wild-Type PKAcα. Structure 27, 816–828 (2019). e814. · doi:10.1016/j.str.2019.03.001
  15. Averill, A. M. et al. Inhibition of the chimeric DnaJ-PKAc enzyme by endogenous inhibitor proteins. J. Cell Biochem. 120, 13783–13791 (2019). · doi:10.1002/jcb.28651
  16. Turnham, R. E. et al. An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma. eLife 8, e44187 (2019). · DOI
  17. Kastenhuber, E. R. et al. DNAJB1–PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma. Proc. Natl Acad. Sci. 114, 13076–13084 (2017). · DOI · Paper page
  18. Wang, Y. et al. Globally correlated conformational entropy underlies positive and negative cooperativity in a kinase’s enzymatic cycle. Nat. Commun. 10, 799 (2019). · DOI · Paper page
  19. Williamson, J. R. Cooperativity in macromolecular assembly. Nat. Chem. Biol. 4, 458–465 (2008). · DOI · Paper page
  20. Knighton, D. R. et al. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253, 414–420 (1991). · DOI · Paper page
  21. Tomasini, M. D. et al. Conformational landscape of the PRKACA-DNAJB1 chimeric kinase, the driver for fibrolamellar hepatocellular carcinoma. Sci. Rep. 8, 720 (2018). · DOI
  22. Masterson, L. R., Mascioni, A., Traaseth, N. J., Taylor, S. S. & Veglia, G. Allosteric cooperativity in protein kinase A. Proc. Natl Acad. Sci. USA 105, 506–511 (2008). · DOI · Paper page
  23. Kim, J., Li, G., Walters, M. A., Taylor, S. S. & Veglia, G. Uncoupling catalytic and binding functions in the cyclic AMP-dependent protein kinase A. Structure 24, 353–363 (2016). · DOI · Paper page
  24. Kay, L. E., Torchia, D. A. & Bax, A. Backbone dynamics of proteins as studied by nitrogen-15 inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. Biochemistry 28, 8972–8979 (1989). · DOI · Paper page
  25. Stark, J. L. et al. Structure and function of human DnaJ homologue subfamily a member 1 (DNAJA1) and its relationship to pancreatic cancer. Biochemistry 53, 1360–1372 (2014). · DOI
  26. Srivastava, AtulK. et al. Synchronous opening and closing motions are essential for cAMP-dependent protein kinase A signaling. Structure 22, 1735–1743 (2014). · DOI · Paper page
  27. Selvaratnam, R., Chowdhury, S., VanSchouwen, B. & Melacini, G. Mapping allostery through the covariance analysis of NMR chemical shifts. Proc. Natl Acad. Sci. USA 108, 6133–6138 (2011). · DOI · Paper page
  28. Boulton, S., Akimoto, M., Selvaratnam, R., Bashiri, A. & Melacini, G. A tool set to map allosteric networks through the NMR chemical shift covariance analysis. Sci. Rep. 4, 7306 (2014). · DOI
  29. Boulton, S., Selvaratnam, R., Ahmed, R. & Melacini, G. Implementation of the NMR CHEmical Shift Covariance Analysis (CHESCA): a chemical biologist’s approach to allostery. Methods Mol. Biol. 1688, 391–405 (2018). · DOI · Paper page
  30. Ahuja, L. G., Kornev, A. P., McClendon, C. L., Veglia, G. & Taylor, S. S. Mutation of a kinase allosteric node uncouples dynamics linked to phosphotransfer. Proc. Natl Acad. Sci. 114, E931–E940 (2017). · DOI · Paper page
  31. McClendon, C. L., Kornev, A. P., Gilson, M. K. & Taylor, S. S. Dynamic architecture of a protein kinase. Proc. Natl Acad. Sci. USA 111, E4623–4631 (2014). · DOI · Paper page
  32. Cembran, A., Kim, J., Gao, J. & Veglia, G. NMR mapping of protein conformational landscapes using coordinated behavior of chemical shifts upon ligand binding. Phys. Chem. Chem. Phys. 16, 6508–6518 (2014). · DOI · Paper page
  33. Kim, J. et al. Dysfunctional conformational dynamics of protein kinase A induced by a lethal mutant of phospholamban hinder phosphorylation. Proc. Natl Acad. Sci. 112, 3716–3721 (2015). · DOI
  34. Vyas, M. et al. DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma. Mod. Pathol. https://doi.org/10.1038/s41379-019-0398-2 (2019). · DOI
  35. Singhi, A. D. et al. Recurrent rearrangements in PRKACA and PRKACB in intraductal oncocytic papillary neoplasms of the pancreas and bile duct. Gastroenterology 158, 573–582 (2020). · DOI · Paper page
  36. Riggle, K. M., Turnham, R., Scott, J. D., Yeung, R. S. & Riehle, K. J. Fibrolamellar hepatocellular carcinoma: mechanistic distinction from adult hepatocellular carcinoma. Pediatr. Blood Cancer https://doi.org/10.1002/pbc.25970 (2016). · DOI
  37. Graham, R. P. et al. Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion. Hepatology 68, 1441–1447 (2018). · DOI
  38. Kamilaris, C. D. C., Faucz, F. R., Voutetakis, A. & Stratakis, C. A. Carney complex. Exp. Clin. Endocrinol. Diabetes 127, 156–164 (2019). · DOI
  39. Zhang, P. et al. An isoform-specific myristylation switch targets type II PKA holoenzymes to membranes. Structure 23, 1563–1572 (2015). · doi:10.1016/j.str.2015.07.007
  40. Tillo, S. E. et al. Liberated PKA catalytic subunits associate with the membrane via myristoylation to preferentially phosphorylate membrane substrates. Cell Rep. 19, 617–629 (2017). · DOI
  41. Whitty, A. Cooperativity and biological complexity. Nat. Chem. Biol. 4, 435–439 (2008). · DOI · Paper page
  42. Wiseman, T., Williston, S., Brandts, J. F. & Lin, L.-N. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal. Biochem. 179, 131–137 (1989). · DOI · Paper page
  43. Cook, P. F., Neville, M. E. Jr., Vrana, K. E., Hartl, F. T. & Roskoski, R. Jr. Adenosine cyclic 3’,5’-monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit. Biochemistry 21, 5794–5799 (1982). · DOI · Paper page
  44. Shi, L. & Kay, L. E. Tracing an allosteric pathway regulating the activity of the HslV protease. Proc. Natl Acad. Sci. 111, 2140–2145 (2014). · DOI
  45. Wang, J. et al. Mapping allosteric communications within individual proteins. Nat. Commun. 11, 3862 (2020). · DOI · Paper page
  46. Tong, M. et al. Survey of solution dynamics in Src kinase reveals allosteric cross talk between the ligand binding and regulatory sites. Nat. Commun. 8, 2160 (2017). · DOI
  47. Lu, S. et al. The mechanism of ATP-dependent allosteric protection of Akt kinase phosphorylation. Structure 23, 1725–1734 (2015). · DOI
  48. Ni, D., Song, K., Zhang, J. & Lu, S. Molecular dynamics simulations and dynamic network analysis reveal the allosteric unbinding of monobody to H-Ras triggered by R135K mutation. Int. J. Mol. Sci. 18, 2249 (2017). · DOI
  49. Rivalta, I. et al. Allosteric communication disrupted by a small molecule binding to the imidazole glycerol phosphate synthase protein–protein interface. Biochemistry 55, 6484–6494 (2016). · DOI
  50. Marsiglia, W. M. et al. A conserved allosteric pathway in tyrosine kinase regulation. Structure 27, 1308–1315 (2019). e1303. · DOI
  51. Shibata, T., Arai, Y. & Totoki, Y. Molecular genomic landscapes of hepatobiliary cancer. Cancer Sci. 109, 1282–1291 (2018). · DOI
  52. Schneidman-Duhovny, D., Hammel, M. & Sali, A. FoXS: a web server for rapid computation and fitting of SAXS profiles. Nucleic Acids Res. 38, W540–W544 (2010). · DOI · Paper page
  53. Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293 (1995). · DOI · Paper page
  54. Lee, W., Tonelli, M. & Markley, J. L. NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy. Bioinformatics 31, 1325–1327 (2015). · DOI · Paper page
  55. Hanks, S., Quinn, A. & Hunter, T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241, 42–52 (1988). · DOI · Paper page
  56. Zheng, J. et al. 2.2 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor. Acta Crystallogr. Sect. D. 49, 362–365 (1993). · DOI · Paper page
  57. Hess, B., Kutzner, C., van der Spoel, D. & Lindahl, E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput 4, 435–447 (2008). · DOI · Paper page
  58. Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles. J. Chem. Theory Comput. 8, 3257–3273 (2012). · DOI · Paper page
  59. Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926 (1983). · DOI · Paper page
  60. Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463–1472 (1997). · DOI · Paper page
  61. Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: an N⋅log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089 (1993). · DOI · Paper page
  62. Parrinello, M. & Rahman, A. Crystal structure and pair potentials: a molecular-dynamics study. Phys. Rev. Lett. 45, 1196–1199 (1980). · DOI · Paper page

Cited by

See all 28

Metadata

Authors
Olivieri, C., Walker, C., Karamafrooz, A., Wang, Y., Manu, V. S., Porcelli, F., Blumenthal, D. K., Thomas, D. D., Bernlohr, D. A., Simon, S. M., Taylor, S. S., & Veglia, G.
Venue
Communications Biology
Published
2021-03-10
Volume
4
Issue
1
ISSN
2399-3642
Cited by
28
References
2
Language
en
Licence
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM 100310, OD021536)
  • American Heart Association (20PRE35120253)
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL139065)
  • U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG26160)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A. https://app.cochat.ai/papers/10.1038/s42003-021-01819-6
The paper
Olivieri, C., Walker, C., Karamafrooz, A., Wang, Y., Manu, V. S., Porcelli, F., Blumenthal, D. K., Thomas, D. D., Bernlohr, D. A., Simon, S. M., Taylor, S. S., & Veglia, G. (2021). Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A. Communications Biology. https://doi.org/10.1038/s42003-021-01819-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.